Product: Bupropion Hydrochloride Extended-Release Tablets, USP  (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05),  b) 500-count bottle (NDC 68001-264-03) , Rx only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India  For BluePoint Laboratories
Reason for recall: Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.
Recall initiated: 20161027
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated